MERRILL R. OSHEROFF, PH.D.

Corporate Board Profile

Tech Score: 0/100

Inotiv, Inc.

Filing Date	Source Excerpt
2014-02-06	Merrill R. Osheroff, Ph.D. was elected as a director of the Company on January 25, 2014 to replace the vacant seat left by Dr. David Crabb. Dr. Osheroff is currently a scientific consultant for regulatory and drug development strategies as well as regulatory submissions and program monitoring and management.
2015-01-29	Merrill R. Osheroff, Ph.D. was elected as a director of the Company on January 25, 2014. Dr. Osheroff is currently a scientific consultant for regulatory and drug development strategies as well as regulatory submissions and program monitoring and management. From 2006 to 2007, he served as Senior Program Director at Battelle Memorial Institute. Prior to that, he served as Executive Director and Site Head of Worldwide Safety Sciences for Pfizer Corporation in Kalamazoo, Michigan. Dr. Osheroff received his Bachelor of Science in Animal Sciences from the University of Maryland and his Ph.D. in Experimental Pathology and Laboratory Medicine/Toxicology from the University of Wisconsin. Dr. Osheroff brings to the Board intimate knowledge of contract research organizations from his extensive experience with nonclinical contract research organizations.

Filing Date

Source Excerpt

2014-02-06

Merrill R. Osheroff, Ph.D. was elected as a director of the Company on January 25, 2014 to replace the vacant seat left by Dr. David Crabb. Dr. Osheroff is currently a scientific consultant for regulatory and drug development strategies as well as regulatory submissions and program monitoring and management.

2015-01-29

Merrill R. Osheroff, Ph.D. was elected as a director of the Company on January 25, 2014. Dr. Osheroff is currently a scientific consultant for regulatory and drug development strategies as well as regulatory submissions and program monitoring and management. From 2006 to 2007, he served as Senior Program Director at Battelle Memorial Institute. Prior to that, he served as Executive Director and Site Head of Worldwide Safety Sciences for Pfizer Corporation in Kalamazoo, Michigan. Dr. Osheroff received his Bachelor of Science in Animal Sciences from the University of Maryland and his Ph.D. in Experimental Pathology and Laboratory Medicine/Toxicology from the University of Wisconsin. Dr. Osheroff brings to the Board intimate knowledge of contract research organizations from his extensive experience with nonclinical contract research organizations.

Data sourced from SEC filings. Last updated: 2025-08-30